The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 27, 2024

Filed:

Aug. 04, 2021
Applicant:

Florida A&m University, Tallahassee, FL (US);

Inventors:

Mandip Sachdeva, Tallahassee, FL (US);

Arvind Bagde, Tallahassee, FL (US);

Satyanarayan Dev, Tallahassee, FL (US);

Assignee:

Florida A&M University, Tallahassee, FL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61M 37/00 (2006.01); A61K 9/00 (2006.01); A61K 31/192 (2006.01); A61K 31/277 (2006.01); B33Y 70/00 (2020.01); B33Y 80/00 (2015.01);
U.S. Cl.
CPC ...
A61K 9/0021 (2013.01); A61K 31/192 (2013.01); A61K 31/277 (2013.01); A61M 37/0015 (2013.01); B33Y 70/00 (2014.12); B33Y 80/00 (2014.12); A61M 2037/0023 (2013.01); A61M 2037/0053 (2013.01); A61M 2037/0061 (2013.01);
Abstract

A biocompatible resin composition that is used in the manufacture of a dissolvable microneedle that is used for the transdermal delivery of one or more active pharmaceutical ingredients to a subject. The biocompatible resin composition includes lithium phenyl-2,4,6-trimethylbenzoylphospinate, water, and poly(ethylene glycol) diacrylate (molecular weight 550), and may include methacrylated hyaluronic acid, that is capable of forming a structurally stable microneedle patch. The microneedle patch is formulated with the biocompatible resin composition using a continuous, one-step process utilizing additive manufacturing. Once manufactured, the microneedle patches are formulated to adhere to an outer layer of a subject's skin. Once administered to the subject, the microneedle compositions create microscopic pathways into the subject's subdermal layers to deliver one or more active agents to the subject, such as to the subject's bloodstream.


Find Patent Forward Citations

Loading…